ObjectiveTo systematically review the efficacy of acupuncture for PCOS infertility.MethodsPubMed, EMbase, The Cochrane Library, CNKI, WanFang Data, VIP and CBM databases were electronically searched to collect randomized controlled trials (RCTs) of acupuncture for PCOS infertility from inception to January 5th, 2020. Two reviewers independently screened literature, extracted data and assessed risk of bias of included studies. Meta-analysis was then performed using RevMan 5.3 software.ResultsA total of 28 RCTs involving 2 192 patients were included. The results of meta-analysis showed that compared with western medicine alone, acupuncture could increase the pregnancy rate (RR=1.80, 95%CI 1.45 to 2.23, P<0.000 01) and ovulation rate (RR=1.33, 95%CI 1.15 to 1.54, P=0.000 1), and reduce levels of LH (SMD=?0.62, 95%CI ?0.96 to ?0.28, P=0.000 4) and LH/FSH (SMD=?0.65, 95%CI ?1.02 to ?0.29, P=0.000 5). Acupuncture combined with western medicine could increase the pregnancy rate (RR=1.75, 95% CI 1.50 to 2.03, P<0.000 01) and ovulation rate (RR=1.29, 95%CI 1.18 to 1.41, P<0.000 01), decrease levels of LH (SMD=?1.09, 95%CI ?1.64 to ?0.53, P=0.000 1), LH/FSH (SMD=?1.30, 95%CI ?2.35 to ?0.25, P=0.02), and levels of T (SMD=?1.13, 95%CI ?1.59 to ?0.66, P<0.000 01).ConclusionsCurrent evidence shows that acupuncture alone or combined with western medicine can significantly improve ovulation rate, pregnancy rate and reduce hormone level. Due to limited quality and quantity of the included studies, more high-quality studies are required to verify above conclusions.
ObjectiveTo investigate the effect of laparoscopic surgery combined with the following treatment of gonadotropin-releasing hormone agonist (GnRH-a) on the patients with endometriotic infertility and the value of endometriosis fertility index (EFI) system on forecasting the pregnancy outcome. MethodsFrom January 2005 to July 2011, the clinical data of 15 patients with endometriotic infertility patients were analyzed retrospectively. All the patients underwent laparoscopic surgery, and the effect was evaluated according to the endometriosis fertility index (EFI). Then all the patients were divided randomly into two groups on the basis of the different assisted treatment after the laparoscopic surgery:the control group (without any other therapy) and the GnRh-a group (combined with GnRH-a). Eventually, the pregnant rates were calculated respectively in the different groups or according to the different EFI. ResultsAt last, 103 cases finished the follow-up. The pregnancy rate in the control group after 6 months, 1 year and 3 years therapy were 12.5%, 31.2%, and 41.7%, respectively; while in the GnRh-a group were 0%, 16.3%, and 40.0%, respectively. There were no difference between the two groups after the 1 year and 3 years therapy (P>0.05). Besides, all of the 55 cases in the GnRh-a group had side-effects, but no severe adverse effect was encountered. All the side-effects were disappeared after stopping the treatment. The pregnancy rate of the patients with the EFI score of 8-10 was respectively 31.3% 1 year and 62.5% 3 years after the treatment. However, the pregnancy rate of the patients with the EFI score of 5-7 was respectively 15.2% 1 year and 26.0% 3 years after the treatment. There were only 9 patients with the EFI score of 0-4, and all of them were not pregnant. The EFI score had positive correlation with the pregnancy rate 1 year and 3 years after the treatment (rs=0.204, P=0.039; rs=0.437, P<0.001). ConclusionThe treatment of GnRh-a after the laparoscopic surgery can not only increase the rate of the pregnancy, but also delay the pregnancy occasion and increase the occurrence of the side-effects. The EFI may be valuable for forecasting the rate of pregnancy in patients with endometriotic infertility. The patients with EFI score higher than 8 may expect the pregnancy, while the ones with below 7 probably have much lower rate of natural pregnancy rate.
目的:比較不同麻醉方法在腹腔鏡婦科不孕檢查及治療術中的效果和安全性。方法:選擇不孕擬在腹腔鏡下行檢查及治療術的患者60例,隨機分為三組,每組20人,分別進行連續硬膜外麻醉(簡稱EA組);靜吸復合全身麻醉(簡稱GA組);連續硬膜外麻醉加靜吸復合全身麻醉(簡稱EGA組),觀察比較三種麻醉方法對患者呼吸,循環及麻醉效果的影響。結果:三種麻醉方法均可保證手術完成,EA組術中管理較為麻煩,GA組循環波動大,EGA組麻醉效果更好,各種藥物用量減少,患者血液動力學更穩定,恢復快,管理更輕松。結論:連續硬膜外麻醉加靜吸復合全身麻醉(EGA)可避免其它兩種麻醉方式不足,各取長處,更適用于腹腔鏡婦科不孕檢查及治療術麻醉。
現有治療排卵功能障礙性不孕的臨床證據如下,①克羅米酚.1個系統評價結果表明,對不規則排卵婦女,克羅米酚與安慰劑相比,明顯提高了妊娠率.另外4個克羅米酚和他莫昔芬的研究表明,這兩種藥物對排卵率和妊娠率的影響無統計學差異.1個隨機對照試驗(RCT)表明,6個月療程的克羅米酚加二甲雙胍比單用克羅米酚可明顯提高妊娠率.②環芬尼:1個RCT表明,環芬尼與安慰劑相比,對妊娠率的影響無統計學差異.③促性腺激素(HMG):1個系統評價表明,HMG治療與尿促卵泡素(urofollitropin)治療相比,兩者妊娠率無統計學差異.2個RCT表明,重組的促濾泡素和尿促卵泡素治療相比,兩者的持續妊娠率和活產率無統計學差異.以往的研究發現,雖然僅限于那些沒有配合使用GnRHa的婦女,但HMG與尿促卵泡素治療相比,發生卵巢過度刺激綜合征的危險性較小.觀察性研究證據表明,促性腺激素使用可能使卵巢非侵襲性腫瘤發病及多胎妊娠發生增加.④腹腔鏡下卵巢打孔:1個系統評價和其后的1個小樣本RCT表明,促性腺激素治療和卵巢打孔治療相比,對妊娠率影響的無統計學差異,但卵巢打孔術后多胎妊娠的發生率明顯較低.促性腺激素脈沖療法:有1個系統評價結果,但沒有發現促性腺激素脈沖療法有效.
Objective To systematically evaluate the efficacy and safety of letrozole combined with metformin in the treatment of polycystic ovarian syndrome (PCOS) infertility. Methods PubMed, Cochrane Library, Embase, China National Knowledge Infrastructure, Chongqing VIP, Wanfang, and SinoMed were searched from establishment to December 31, 2022. The literature on randomized controlled trials of letrozole combined with metformin in the treatment of PCOS infertility were included. RevMan 5.4 software was used for meta-analysis. Results A total of 29 articles including 3226 subjects were included, with trial group of 1614 treated with letrozole combined with metformin, and control group of 1612 treated with letrozole alone. The meta-analysis results showed that the clinical pregnancy rate [relative risk (RR)=1.76, 95% confidence interval (CI) (1.61, 1.92)], induced ovulation rate [RR=1.22, 95%CI (1.17, 1.28)], and number of dominant follicles [mean difference (MD)=1.15, 95%CI (0.86, 1.43)] in the trial group were higher than those in the control group (P<0.05). The follicle growth time [MD=?5.41 d, 95%CI (?6.03, ?4.80) d], estradiol level [MD=?7.57 pmol/L, 95%CI (?10.59, ?4.56) pmol/L], luteinizing hormone level [MD=?2.27 U/L, 95%CI (?2.59, ?1.95) U/L], testosterone level [MD=?1.29 nmol/L, 95%CI (?1.74, ?0.85) nmol/L], fasting blood glucose level [MD=?0.91 mmol/L, 95%CI (?1.71, ?0.65) mmol/L], fasting insulin level [MD=?25.93 pmol/L, 95%CI (?29.06, ?22.80) pmol/L], insulin resistance index [MD=?1.40, 95%CI (?1.61, ?1.19)], and the incidence of ovarian hyperstimulation syndrome [RR=0.44, 95%CI (0.22, 0.88)] in the trial group were lower than those in the control group (P<0.05). There was no statistically significant difference in follicle stimulating hormone level, incidence of adverse reactions, and spontaneous abortion rates between the two groups (P>0.05). Conclusion Existing evidence suggests that compared to using trazole alone, the combination of letrozole and metformin can improve ovulation induction and pregnancy outcomes in patients with PCOS infertility. The combination of the two drugs can reduce levels of estradiol, testosterone, and luteinizing hormone in patients, while effectively reducing the incidence of ovarian hyperstimulation syndrome.
【摘要】 目的 觀察腹腔鏡手術聯合孕三烯酮治療子宮內膜異位癥合并不孕的療效及不同評分系統對妊娠結局的預測價值。 方法 回顧性分析2004年1月-2006年12月收治的97例子宮內膜異位癥合并不孕患者的臨床病理資料，統計其術后妊娠率及活產率。 結果 術后1年內與1~2年的妊娠率與活產率比較，差異均無統計學意義（Pgt;0.05）。根據美國生育協會1985年修訂的子宮內膜異位癥分期標準（r-AFS）進行分期，各期患者術后妊娠率差異無統計學意義（Pgt;0.05）；但隨著分期升高，活產率逐漸下降（Plt;0.05）。子宮內膜異位癥生育指數（EFI）評分越高，其妊娠率和活產率也越高（Plt;0.05）。 結論 子宮內膜異位癥患者腹腔鏡手術后聯用孕三烯酮可能會提高遠期妊娠率。r-AFS分期對妊娠結局的預測有一定局限性，而EFI具有較好的預測性。【Abstract】 Objective To evaluate the therapeutic effectiveness of laparoscopic surgery combined with gestrinone treatment in the infertile women with endometriosis (EM), and the value of different score systems to predict gestational outcome. Methods We retrospectively analyzed the clinical data of 97 infertile women with EM who were treated in our hospital from January 2004 to December 2006, and collected their pregnancy rate (PR) and live birth rate (LBR) after operation. Results There was no significant difference of PR and LBR within the 1st year and between the 1st and the 2nd year (Pgt;0.05). There was no significant difference of PR among women of various stages of EM based on the 1985 edition of risk stratification for patients with EM put forward by American Fertility Society (r-AFS) (Pgt;0.05), but the LBR decreased with the raising of the stages (Plt;0.05). The endometriosis fertility index (EFI) was positively correlated with PR and LBR (Plt;0.05). Conclusion Laparoscopic surgery combined with gestrinone may increase the long-term pregnancy rate of women with EM. R-AFS classification is limited in predicting the gestational outcome of women with EM, while EFI achieves a better result.
①關于藥物引起的卵巢抑制:1篇系統評價發現,使用卵巢抑制藥治療子宮內膜異位癥與安慰劑或達那唑相比,妊娠率無明顯差異.該評價還發現,卵巢抑制藥引起的不良反應包括體重增加、潮熱和骨質疏松癥,達那唑可能引起劑量相關的體重增加和雄激素樣作用. ②宮腔內人工授精+促性腺激素:1個RCT發現,宮腔內人工授精+促性腺激素治療與不治療相比,可明顯提高活產率.第2個RCT發現,期待療法與宮腔內人工授精+垂體降調節+促性腺激素治療后的分娩率無明顯差異.第3個RCT發現,宮腔內人工授精+促性腺激素治療與單用宮腔內人工授精相比,僅明顯提高妊娠率. ③體外受精:我們沒有找到關于子宮內膜異位癥引起不孕婦女接受受精體外治療的RCT. ④手術治療:兩個比較腹腔鏡手術與診斷性腹腔鏡的RCT發現,在妊娠率和活產率方面結論不一.